MIM
MetLife Investment Management Portfolio holdings
AUM
$17B
1-Year Return
25.61%
This Quarter Return
+9.7%
1 Year Return
+25.61%
3 Year Return
+108.53%
5 Year Return
+194.13%
10 Year Return
–
AUM
$13.7B
AUM Growth
-$178M
(-1.3%)
Cap. Flow
-$1.14B
Cap. Flow
% of AUM
-8.28%
Top 10 Holdings %
Top 10 Hldgs %
25.57%
Holding
3,040
New
254
Increased
776
Reduced
1,044
Closed
101
Top Buys
| 1 |
Palo Alto Networks
PANW
|
+$18.2M |
| 2 |
Meta Platforms (Facebook)
META
|
+$17.3M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$9.06M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$8.12M |
| 5 |
Crown Holdings
CCK
|
+$5.67M |
Top Sells
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$901M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$75.6M |
| 3 |
Apple
AAPL
|
+$12.5M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$11.6M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$8.7M |
Sector Composition
| 1 | Technology | 26.04% |
| 2 | Healthcare | 12.55% |
| 3 | Financials | 11.14% |
| 4 | Consumer Discretionary | 11.03% |
| 5 | Industrials | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Rocket Pharmaceuticals
RCKT
$341M
| $574K | ﹤0.01% |
28,906
+720
| +3% | +$14.3K |
|
1602
Exact Sciences
EXAS
$10.2B
| $574K | ﹤0.01% |
6,115
+1,233
| +25% | +$116K |
|
1603
Open Lending Corp
LPRO
$252M
| $574K | ﹤0.01% |
54,618
-4,109
| -7% | -$43.2K |
|
1604
Stellar Bancorp
STEL
$1.61B
| $574K | ﹤0.01% |
25,073
+562
| +2% | +$12.9K |
|
1605
Inspire Medical Systems
INSP
$2.37B
| $573K | ﹤0.01% |
1,766
-13,227
| -88% | -$4.29M |
|
1606
Logitech
LOGI
$16B
| $573K | ﹤0.01% |
9,636
| – | – |
|
1607
Napco Security Technologies
NSSC
$1.5B
| $572K | ﹤0.01% |
16,507
| – | – |
|
|
PWSC
1608
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $572K | ﹤0.01% |
29,874
+5,035
| +20% | +$96.4K |
|
1609
AerCap
AER
$21.8B
| $572K | ﹤0.01% |
9,000
| – | – |
|
1610
Arcus Biosciences
RCUS
$1.23B
| $571K | ﹤0.01% |
28,134
+1,203
| +4% | +$24.4K |
|
1611
SFL Corp
SFL
$1.06B
| $571K | ﹤0.01% |
61,230
| – | – |
|
|
EVBG
1612
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $569K | ﹤0.01% |
21,154
+529
| +3% | +$14.2K |
|
1613
Scholastic
SCHL
$691M
| $568K | ﹤0.01% |
14,613
-1,010
| -6% | -$39.3K |
|
|
CBAY
1614
DELISTED
Cymabay Therapeutics
CBAY
| $567K | ﹤0.01% |
+51,802
| New | +$567K |
|
1615
FIGS
FIGS
$1.16B
| $567K | ﹤0.01% |
68,535
| – | – |
|
1616
National Bank Holdings
NBHC
$1.46B
| $566K | ﹤0.01% |
19,494
+3,784
| +24% | +$110K |
|
1617
Weis Markets
WMK
$1.75B
| $565K | ﹤0.01% |
8,795
| – | – |
|
1618
Sabre
SABR
$738M
| $565K | ﹤0.01% |
176,970
+7,152
| +4% | +$22.8K |
|
1619
S&T Bancorp
STBA
$1.5B
| $564K | ﹤0.01% |
20,743
| – | – |
|
1620
Employers Holdings
EIG
$983M
| $564K | ﹤0.01% |
15,066
+607
| +4% | +$22.7K |
|
1621
Aehr Test Systems
AEHR
$793M
| $563K | ﹤0.01% |
+13,653
| New | +$563K |
|
1622
RB Global
RBA
$21.7B
| $563K | ﹤0.01% |
9,382
+5,604
| +148% | +$336K |
|
1623
Gulfport Energy Corp
GPOR
$3.06B
| $562K | ﹤0.01% |
5,353
-1,057
| -16% | -$111K |
|
1624
Global Net Lease
GNL
$1.81B
| $559K | ﹤0.01% |
54,350
| – | – |
|
1625
Apellis Pharmaceuticals
APLS
$3.14B
| $558K | ﹤0.01% |
6,126
-42,949
| -88% | -$3.91M |
|